LncRNA PVT1/miR-9-5p轴在肺炎链球菌诱导肺泡上皮细胞损伤中的作用及机制

Role and mechanism of LncRNA PVT1/miR-9-5p axis in Streptococcus pneumoniae-induced alveolar epithelial cell injury

  • 摘要: 目的 探究长链非编码RNA(LncRNA)人浆细胞瘤转化迁移基因1(PVT1)靶向miR-9-5p对肺炎链球菌(Sp)诱导的肺泡上皮细胞损伤的影响。方法 选取人肺泡上皮细胞(HPAEpiC),分组分为:Control组(常规培养)、Sp组(采用1×108 CFU/ml Sp感染细胞)、sh-NC组(Sp诱导+转染sh-NC)、sh-PVT1组(Sp诱导+转染sh-PVT1)、sh-PVT1+anti-NC组(Sp诱导+转染sh-PVT1、anti-NC),sh-PVT1+anti-miR-9-5p组(Sp诱导+转染sh-PVT1、anti-miR-9-5p)。实时荧光定量逆转录聚合酶链式反应法检测细胞LncRNA PVT1、miR-9-5p表达;CCK8和克隆形成实验检测细胞增殖;流式细胞仪检测细胞凋亡率;酶联免疫吸附试验法检测细胞中炎症指标表达;蛋白质免疫印迹检测细胞中蛋白表达;双荧光素酶实验检测LncRNA PVT1与miR-9-5p的靶向关系。结果 Sp组细胞LncRNA PVT1表达、凋亡率、肿瘤坏死因子-α(TNF-α)、白细胞介素(IL)-6水平、P21、Bax蛋白表达高于Control组(P<0.05),miR-9-5p表达、存活率、克隆数、IL-10水平、Bcl-2蛋白表达低于Control组(P<0.05);sh-PVT1组细胞LncRNA PVT1表达、凋亡率、TNF-α、IL-6水平、P21、Bax蛋白表达低于Sp组、sh-NC组(P<0.05),miR-9-5p表达、存活率、克隆数、IL-10水平、Bcl-2蛋白表达高于Sp组、sh-NC组(P<0.05);与sh-PVT1组、sh-PVT1+anti-NC组相比,sh-PVT1+anti-miR-9-5p组细胞凋亡率、TNF-α、IL-6水平、P21、Bax蛋白表达升高(P<0.05),miR-9-5p表达、存活率、克隆数、IL-10水平、Bcl-2蛋白表达降低(P<0.05);与PVT1-WT+mimic-NC组相比,PVT1-WT+miR-9-5p mimic组细胞双荧光素酶活性明显降低(P<0.05)。结论 LncRNA PVT1可靶向抑制miR-9-5p表达,促进肺泡上皮细胞损伤。

     

    Abstract: OBJECTIVE To investigate the effect of long non-coding RNA (LncRNA) plasmacytoma variant translocation 1 (PVT1) targeting miR-9-5p on alveolar epithelial cell injury induced by Streptococcus pneumoniae (Sp). METHODS Human pulmonary alveolar epithelial cells (HPAEpiC) were selected and randomly divided into the following groups: Control group (conventional culture), Sp group (cells infected with Sp at 1×108 CFU/ml), sh-NC group (Sp induction + transfected with sh-NC), sh-PVT1 group (Sp induction + transfected with sh-PVT1), sh-PVT1 + anti-NC group (Sp induction + transfected with sh-PVT1 and anti-NC) and sh-PVT1 + anti-miR-9-5p group (Sp induction + transfected with sh-PVT1 and anti-miR-9-5p). Real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) was employed to detect the expression of LncRNA PVT1 and miR-9-5p in cells. CCK8 assay and colony formation assay were conducted to assess cell proliferation. Apoptosis rate was measured by flow cytometry. Enzyme-linked immunosorbent assay (ELISA) was conducted to determine the expression of inflammatory markers in cells. Protein expression was analyzed via Western blotting. The targeting relationship between LncRNA PVT1 and miR-9-5p was verified by dual-luciferase reporter assay. RESULTS The Sp group exhibited higher levels of LncRNA PVT1 expression, apoptosis rate, tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), P21 and Bax protein expression compared to the Control group (P<0.05), while miR-9-5p expression, survival rate, colony count, IL-10 levels and Bcl-2 protein expression were lower (P<0.05). The sh-PVT1 group showed lower LncRNA PVT1 expression, apoptosis rate, TNF-α, IL-6 levels, P21 and Bax protein expression compared to the Sp and sh-NC groups (P<0.05), whereas miR-9-5p expression, survival rate, colony count, IL-10 levels and Bcl-2 protein expression were higher (P<0.05). Compared to the sh-PVT1 and sh-PVT1+anti-NC groups, the sh-PVT1+anti-miR-9-5p group demonstrated increased apoptosis rate, TNF-α, IL-6 levels, P21 and Bax protein expression (P<0.05), alongside decreased miR-9-5p expression, survival rate, colony count, IL-10 levels and Bcl-2 protein expression (P<0.05). The PVT1-WT+miR-9-5p mimic group exhibited significantly lower dual-luciferase activity than the PVT1-WT+mimic-NC group (P<0.05). CONCLUSION LncRNA PVT1 can target and inhibit miR-9-5p expression, thereby inducing alveolar epithelial cell injury.

     

/

返回文章
返回